BridgeBio Pharma Prices Stock Offering to Raise $250M
Wednesday, 6 March 2024, 10:59
BridgeBio Pharma Announces Pricing of $250M Stock Offering
BridgeBio Pharma has announced the pricing of a stock offering to raise $250M in gross proceeds. The offering comprises 8.62M shares priced at $29 each.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.